SAMUEL SMITH: Open Payments
NPI 1295802700 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,427 in 60 payments from 5 companies in 2025. Trend: 2023 $2,205 · 2024 $1,891 · 2025 $2,427
Food & beverage: $2,427
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 22 | $859 |
| Janssen Pharmaceuticals, Inc | 13 | $785 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $437 |
| ABBVIE INC. | 15 | $285 |
| Janssen Scientific Affairs, LLC | 1 | $60 |
Products named: INVEGA SUSTENNA, ARISTADA, CAPLYTA, VRAYLAR, LYBALVI.
Industry payments across CA — which companies pay providers there.
